Global Electrosurgical Devices Market - 2025 - 2033

Global Electrosurgical Devices Market - 2025 - 2033

The global electrosurgical devices market reached US$ 6.27 billion in 2023 and is expected to reach US$ 9.10 billion by 2033, growing at a CAGR of 3.7% during the forecast period 2025-2033.

The electrosurgical unit, also known as the Bovie, is a surgical tool used to incise, destroy tissue through desiccation, and control bleeding by coagulating blood. It uses a high-powered generator to produce a radiofrequency spark between a probe and the surgical site, causing localized heating and tissue damage. The generator operates in two modes: monopolar, where an active electrode concentrates current to the site, and bipolar, where both electrodes are located at the surgical site.

Market Dynamics: Drivers & Restraints

Rise in Technological Advancements

Technological advancements have significantly shaped the global electrosurgical devices market, enhancing precision and safety in procedures. This includes minimally invasive techniques, robotic-assisted systems, and advanced energy-based modalities. These advancements help healthcare providers achieve better patient outcomes with reduced recovery times and complications. The integration of intelligent systems and data analytics has improved device functionality. As technology evolves, electrosurgical devices are adopted across various medical disciplines, contributing to the market's growth.

For instance, in August 2024, Olympus has introduced two new jaw designs in its PowerSeal sealer/divider portfolio: the PowerSeal Curved Jaw, double-action (SJDA) and PowerSeal Curved Jaw, single-action (CJSA). These devices support dissection, grasping, and sealing techniques during surgery, promoting procedural efficiency and comfort. Olympus claims that the PowerSeal design requires less squeeze force than competitor instruments to close the jaws, without compromising jaw force or sealing capability. These single-use devices can be used in laparoscopic and open surgery.

High Cost of the Devices

The global electrosurgical devices market faces challenges due to the high cost of advanced technologies, a significant barrier for healthcare facilities in low- and middle-income regions. These costs, coupled with the need for specialized training and technical expertise, can limit access to state-of-the-art equipment. Despite the potential to improve surgical outcomes and efficiency, the high cost of these devices may hinder their widespread adoption.

For instance, Electrosurgical devices can range from $5000 to $15,000 USD, with well-known brands like Covidien, Ellman, and Erbe in the US. Top-selling brands outside the US include Conmed and Sometech. New and demo machines are more expensive than refurbished or used ones. New machines have a manufacturer's warranty and are never used, while demo machines are exhibition models. Refurbished machines have undergone improvements and can be done at the manufacturer's facilities or private repair shops

Segment Analysis

The global electrosurgical devices market is segmented based on product type, application, end user and region.

Product Type:

Electrosurgical Instruments segment is expected to dominate the Electrosurgical Devices market share

The electrosurgical instruments segment holds a major portion of the electrosurgical devices market share and is expected to continue to hold a significant portion of the electrosurgical devices market share during the forecast period.

Electrosurgical instruments, including electrodes, forceps, scissors, and probes, are crucial for precision and minimal tissue damage in various surgical procedures. They are versatile and used in general surgery, gynecology, urology, and orthopedics. Innovations in design, like non-stick coatings and ergonomics, enhance their effectiveness and safety. As demand for minimally invasive procedures increases, the adoption of advanced electrosurgical instruments is expected to drive market expansion, meeting healthcare providers' needs for reliable and efficient surgical tools.

For instance, in January 2023, Cook Medical has introduced a new, streamlined portfolio of urological bipolar electrodes in the U.S., focusing on the most frequently used products for bladder and prostate procedures. The portfolio includes seven products, six of which are specifically designed for transurethral resection, ablation, and soft tissue removal of the prostate and bladder, and where hemostasis is required. The streamlined portfolio is designed to meet the needs of urologists in the field.

Application:

General Surgery segment is the fastest-growing segment in Electrosurgical Devices market share

The general surgery segment is the fastest-growing segment in the electrosurgical devices market share and is expected to hold the market share over the forecast period.

The global electrosurgical devices market is primarily driven by general surgery, which uses these tools for cutting, coagulating, and tissue ablation. These devices offer precision and efficiency, reducing recovery time, blood loss, and complications. As conditions like hernias, appendicitis, and gastrointestinal disorders increase, the demand for electrosurgical devices in general surgery is expected to grow. Advancements in electrosurgical technologies further enhance their application in general surgery, solidifying their critical role in this market segment.

For instance, in 2023, as per NCBI study in the US found that 1 in 9 US households had undergone at least one surgical procedure in the past year, with the highest prevalence among those 65 and older and Medicare beneficiaries, with approximately 1 in 5 reporting such procedures.

Geographical Analysis

North America holds a substantial position in the electrosurgical devices market and is expected to hold most of the market share due to significant investments in medical technologies, and high prevalence of chronic diseases. The region's strong base of leading medical device manufacturers and research institutions drives innovation in electrosurgical technologies. Government initiatives like favorable reimbursement policies and funding for medical advancements contribute to market growth. The widespread adoption of minimally invasive surgical procedures and skilled healthcare professionals further enhance the use of electrosurgical devices.

For instance, in June 2023, Olympus Corporation has announced the availability of its latest electrosurgical generator, the ESG-410, for treating bladder cancer and enlarged prostate. This next-generation generator offers efficiencies in treating NMIBC (non-muscle-invasive bladder cancer) and BPH (enlarged prostate), using various resection loops, band electrodes, and vaporization buttons and needles. The generator supports options and efficiencies in the treatment of these conditions.

Europe is growing at the fastest pace in the Electrosurgical Devices market

Europe holds the fastest pace in the electrosurgical devices market and is expected to hold most of the market share due to established healthcare system and robust regulatory frameworks. The region's focus on improving surgical outcomes and patient safety has led to widespread adoption of advanced electrosurgical technologies. The growing aging population and increasing incidence of chronic diseases like diabetes, cancer, and cardiovascular conditions increase the demand for surgical procedures. Europe's leading medical device manufacturers and research organizations contribute to technological advancements and product development. Government initiatives, reimbursement policies, training programs, and collaborations between healthcare providers and manufacturers further drive market growth.

For instance, in November 2024, Halma PLC has acquired Lamidey Noury Medical for EUR50 Billion, aiming to expand its Healthcare sector. The Paris-based electrosurgical device firm, which is used in urology, gynaecology, and general surgery, is a minimally invasive option used in over 60 countries. The acquisition is funded by existing lending facilities. LNM generated EUR13.6 billion in revenue from the 12 months to October, meeting Halma's target range of 19% to 23%.

Competitive Landscape

The major global players in the electrosurgical devices market include Stryker Corporation, Boston Scientific Corporation, Symmetry Surgical Inc, CONMED Corporation, Medtronic Plc, Ethicon (Johnson and Johnson), B. Braun SE, Smith+Nephew, Olympus Corporation, Abbott Laboratories, OTTek, Dalent Medical, MMI, EGDe Surgical and among others.

Key Developments
• In September 2024, Mindray, a leading global medical equipment manufacturer, showcased its UP700 Electrosurgical Unit at the 27th International Federation for the Surgery of Obesity and Metabolic Disorders World Congress in Melbourne, Australia. The UP700 Electrosurgical Unit was the highlight of the cutting-edge innovations in bariatric and metabolic surgery.
• In April 2023, Innoblative Designs, Inc., a private medical device company, has received Breakthrough Device Designation from the FDA for its SIRA RFA Electrosurgical Device, designed for use in breast cancer patients undergoing lumpectomy.

Why Purchase the Report?
• Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
• Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
• Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
• Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
• Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
• Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
• Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
• Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
• Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
• Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
• Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
• Post-market Surveillance: Uses post-market data to enhance product safety and access.
• Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global electrosurgical devices market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023
• Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
• Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
• Application & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
• Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
• Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
• Supply Chain: Distribution and Supply Chain Managers.
• Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
• Academic & Research: Academic Institutions.